Sen. Christopher Murphy

Maddy summaryThis bill prevents employers from dropping health insurance coverage for workers during strikes or lockouts. It amends the National Labor Relations Act to prohibit employers from terminating group health plan coverage for employees who are either locked out (during bargaining disputes) or participating in a lawful strike. Employers who violate this rule face civil penalties of up to $75,000 per violation for lockout-related actions (doubling to $150,000 for repeat offenses) or $50,000 for strike-related actions (doubling to $100,000 for repeat offenses). The law directly affects workers engaged in strikes or locked out by employers, ensuring their healthcare coverage continues during these labor disputes.

Maddy summaryThis bill repeals key protections in the Protection of Lawful Commerce in Arms Act that shielded gun manufacturers from civil lawsuits. It allows victims of gun violence to use federal gun trace data (from the Firearms Trace System database) as evidence in civil court cases against gun sellers or manufacturers. The law makes this trace information discoverable, admissible, and usable in any civil action in state or federal courts, including the District of Columbia. This change directly affects victims seeking legal recourse and gun industry entities previously protected by the repealed law.

Maddy summaryS 1957, the "No Place for LGBTQ+ Hate Act," repeals five specific executive orders that the bill identifies as harming LGBTQI+ rights. It prohibits federal funding for implementing or enforcing those orders, which include policies restricting transgender healthcare, military service, school sports participation, and requiring schools to deny transgender identities. The bill directly affects LGBTQI+ individuals by reversing discriminatory executive actions in key areas like employment, education, healthcare, and military service. It does not create new policies but formally nullifies existing executive actions through legislative repeal and funding restrictions.

Maddy summaryThe SEPSIS Act establishes a dedicated sepsis program within the Centers for Disease Control and Prevention (CDC) to improve prevention, detection, and treatment of sepsis in hospitals. It requires hospitals to adopt evidence-based sepsis protocols (like the Hospital Sepsis Program Core Elements), report on their implementation, and supports pediatric sepsis data collection. The bill authorizes $20 million annually from 2026-2030 to fund CDC efforts, including annual reports to Congress on hospital adoption rates, pediatric sepsis reduction, and a voluntary "honor roll" program recognizing top-performing hospitals. This directly affects hospitals through reporting requirements and CDC through new program responsibilities.

Maddy summaryThis resolution (SRES 255) is a ceremonial Senate measure honoring former U.S. Senator Christopher "Kit" Bond of Missouri, who died on May 13, 2025. It recognizes his 40+ years of public service, including his roles as Missouri Governor (1973-1977, 1981-1985) and U.S. Senator (1987-2011). The resolution directs the Senate to adjourn briefly as a mark of respect and transmit a copy to his family. It has no policy impact or direct effect on constituents, as it is purely commemorative.

Maddy summaryThe Ban Congressional Stock Trading Act (S 1879) requires current and new Members of Congress, along with their spouses and dependent children, to divest or place certain investments in qualified blind trusts. It defines "covered investments" broadly to include stocks, bonds, commodities, and derivatives, while excluding diversified mutual funds, Treasury securities, and retirement plan investments. Members must complete this process within 120 days of enacting the law (with possible 180-day extensions), and new members have 120 days after taking office to comply. The law mandates public reporting of assets placed in blind trusts and imposes civil penalties for non-compliance, equal to a monthly portion of the member's salary. This legislation directly affects congressional staff members and their immediate families who hold financial interests that could create conflicts of interest.

College for All Act of 2025 This bill establishes measures to expand access to higher education, including by eliminating tuition and required fees for eligible students, revising the Federal Pell Grant program, and reauthorizing certain programs to assist students from disadvantaged backgrounds. Specifically, the bill provides funding to enable states and tribal colleges and universities, through a federal-state partnership, to eliminate tuition and required fees for (1) all students at community colleges and two-year tribal colleges and universities, and (2) working- and middle-class students at four-year public institutions of higher education and tribal colleges and universities. The bill provides funding to enable private, nonprofit historically Black colleges and universities and minority-serving institutions to eliminate tuition and required fees for eligible students. The bill permanently reauthorizes and otherwise revises the Federal Pell Grant program by providing funding to increase the maximum award for each eligible student, increasing the duration limit for the use of Pell Grants, allowing students to use their awards to cover living and nontuition expenses, and expanding eligibility to Dreamer students (i.e., students who have been granted Deferred Action for Childhood Arrivals status and who entered the United States before the age of 16) and students with other immigration statuses. Further, the bill requires the Department of Education to award grants to eligible states and tribal colleges and universities for improving student outcomes. The bill reauthorizes through FY2035 the Federal TRIO Programs and reauthorizes through FY2029 the Gaining Early Awareness and Readiness for Undergraduate Programs.

Maddy summaryThe SMART Prices Act (S 1836) changes how Medicare negotiates drug prices. It increases the number of drugs eligible for negotiation from 15 to 50 per year starting in 2028, shortens the time drugs must be the sole source for eligibility from 7 to 3 years, and adjusts price ceiling percentages for negotiated drugs (e.g., raising the maximum fair price from 75% to 76% for some drugs). These changes directly affect Medicare Part D beneficiaries and pharmaceutical companies by altering the negotiation process and pricing caps. The bill modifies existing Medicare drug pricing rules without creating new programs, applying to initial price negotiations beginning in 2028.

Maddy summaryThis bill increases the age limit for children to remain eligible for medical care under the CHAMPVA program from 21 to 26 years old, regardless of marital status. It directly affects the children of veterans who qualify for CHAMPVA benefits. The key provision amends Section 1781(c) of Title 38, U.S. Code, to extend coverage until a child's 26th birthday. This change applies to medical care provided on or after the bill's enactment date. It does not affect children already covered under specific existing provisions of the law.

Maddy summaryThis bill creates a process for the Secretary of Health and Human Services to determine if brand name drug prices exceed those in five reference countries (Canada, UK, Germany, France, and Japan). If a drug is deemed excessively priced, the government will terminate the manufacturer's exclusivity rights and allow any company to produce a generic version under an open, non-exclusive license with a reasonable royalty. Drug manufacturers must submit detailed annual reports on pricing, costs, and revenues, with penalties for noncompliance. The Secretary will maintain a public database of excessive price determinations and report annually to Congress. This directly impacts brand name drug manufacturers, generic producers, and patients who purchase prescription drugs.